← Zurück zu Insidertransaktionen
MURPHY ANDREW J
Insider · Co-Chief Scientific Officer
Käufe
0
0 USD
Verkäufe
27
3.204.376 USD
Unternehmen
1
mit gemeldeten Geschäften
Letzte Aktivität
14.10.2026
27 Transaktionen gesamt
| Datum | Unternehmen | Position | Art | Volumen | Preis | Stückzahl | Seit Meldung |
|---|---|---|---|---|---|---|---|
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 39.073,50 USD | 781,47 USD | 50 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 361.431,69 USD | 780,63 USD | 463 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 296.244,20 USD | 779,59 USD | 380 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 353.502,56 USD | 778,64 USD | 454 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 29.554,88 USD | 777,76 USD | 38 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 51.236,46 USD | 776,31 USD | 66 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 291.572,96 USD | 775,46 USD | 376 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 93.712,08 USD | 774,48 USD | 121 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 173.241,60 USD | 773,40 USD | 224 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 163.010,16 USD | 772,56 USD | 211 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 218.351,48 USD | 771,56 USD | 283 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 9.242,40 USD | 770,20 USD | 12 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 97.701,10 USD | 769,30 USD | 127 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 80.674,65 USD | 768,33 USD | 105 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 147.338,88 USD | 767,39 USD | 192 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 213.845,13 USD | 766,47 USD | 279 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 207.420,69 USD | 765,39 USD | 271 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 167.403,60 USD | 764,40 USD | 219 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 19.094,00 USD | 763,76 USD | 25 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 41.941,35 USD | 762,57 USD | 55 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 20.556,72 USD | 761,36 USD | 27 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 56.288,10 USD | 760,65 USD | 74 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 10.639,44 USD | 759,96 USD | 14 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 18.195,84 USD | 758,16 USD | 24 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 12.122,88 USD | 757,68 USD | 16 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 26.456,85 USD | 755,91 USD | 35 | – |
| 14.10.2026 |
REGENERON PHARMACEUTICALS, INC.
Co-Chief Scientific Officer
|
Co-Chief Scientific Officer | Verkauf | 4.522,56 USD | 753,76 USD | 6 | – |
Alle von „MURPHY ANDREW J" gemeldeten Eigengeschäfte (Directors' Dealings) gemäß Art. 19 MAR bzw. den jeweiligen nationalen Pflichtmeldungen. Gleiche Personen können unter abweichenden Schreibweisen mehrfach geführt sein. „Seit Meldung" vergleicht den aktuellen Kurs (deutsche Handelsplätze, EUR) mit dem gemeldeten EUR-Preis der Transaktion — Meldungen in anderen Währungen bleiben ohne Angabe. Details in der Methodik.